Cyient's board approves Krishna Bodanapu as Executive Vice Chairman & MD for three years (subject to shareholders); independent directors named for material subsidiaries; Lead Independent Director appointed; Audit & Risk Committee reconstituted. Disclosure aligned with SEBI and stock exchange requirements.